Plus therapeutics, inc. reports earnings results for the third quarter ended september 30, 2019

Plus therapeutics, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced operating income was usd 2.680 million compared to operating loss of usd 2.227 million a year ago. net income was usd 526,000 compared to net loss of usd 2.330 million a year ago. basic loss per share from continuing operations was usd 0.03 compared to usd 22.27 a year ago. basic loss per share was usd 0.03 compared to usd 27.63 a year ago. for the nine months, operating loss was usd 1.444 million compared to usd 6.852 million a year ago. net loss was usd 11.771 million compared to usd 10.398 million a year ago. basic loss per share from continuing operations was usd 8.78 compared to usd 67.09 a year ago. basic loss per share was usd 22.75 compared to usd 92.4 a year ago.
pstv Ratings Summary
pstv Quant Ranking